Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients

<div>ROC curve analysis of serum sST2 in predicting the efficacy of SLIT. ROC: receiver operating characteristic; sST2: soluble suppressor of tumorigenicity 2; SLIT: sublingual immunotherapy.</div>

Mediators of Inflammation

fig4

Figure 4

Figure 4: Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients 

Figure 4 | Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients 